MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study

BACKGROUND: The uncertainties inherent in clinical measures of prostate cancer (CaP) aggressiveness endorse the investigation of clinically validated tissue biomarkers. MUC1 expression has been previously reported to independently predict aggressive localized prostate cancer. We used a large cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Eminaga, Okyaz, Wei, Wei, Hawley, Sarah J., Auman, Heidi, Newcomb, Lisa F., Simko, Jeff, Hurtado-Coll, Antonio, Troyer, Dean A., Carroll, Peter R., Gleave, Martin E., Lin, Daniel W., Nelson, Peter S., Thompson, Ian M., True, Lawrence D., McKenney, Jesse K., Feng, Ziding, Fazli, Ladan, Brooks, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112958/
https://www.ncbi.nlm.nih.gov/pubmed/27846218
http://dx.doi.org/10.1371/journal.pone.0165236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112958/
https://www.ncbi.nlm.nih.gov/pubmed/27846218
http://dx.doi.org/10.1371/journal.pone.0165236

Ejemplares similares